Explore Allbiosyn
Years
Milligrams to hundreds of kilograms large-scale production capacity of nucleotide raw materials
An innovation benchmark in the global nucleic acid drug raw materials field
Allbiosyn (Shanghai) Biotech Co., Ltd. is a rapidly growing biotechnology enterprise specializing in the R&D and production of nucleotide raw materials. Leveraging our proprietary end-to-end innovation platform spanning nucleic acid drug development and manufacturing, we have successfully developed multiple modified nucleosides and functional nucleic acid molecules with independent intellectual property rights.
More
·
Oligonucleotide Synthesis Raw Materials
·
Gene Sequencing And In Vitro Diagnostic Reagents
·
mRNA Vaccine Raw Materials
·
Dye
·
New Series
Explore Allbiosyn products
Allbiosyn is always committed to providing cost-effective and innovative nucleotide raw materials
01
Oligonucleotide Synthesis Raw Materials
| Nucleosides | Modified Nucleosides |
| Protected Nucleosides(PNS) | Phosphoramidites |
| Succinates | Delivery System |
Explore Allbiosyn Services
Allbiosyn Team
Blog
On March 15, 2025, the three-day 2025 E-Trade Bio-industry Conference (BIOCHINA) successfully concluded at Suzhou International Expo Center. This conference, themed "Innovation Without Borders, Collaborative Coexistence," gathered 850 top global speakers and 30,000 professional attendees, covering 50,000㎡ of exhibition space, comprehensively showcasing cutting-edge technologies and industrial potential in the biomedical field. As a leader in the nucleic acid raw material sector, Allbiosyn Bio showcased its core product matrix at the exhibition, to jointly explore the future of nucleic acid drug industrialization with global partners.
2025-03-18
2025-03-18
Imetelstat is the world's first approved telomerase inhibitor drug, developed by Geron Corporation in the United States, and approved by the FDA on June 6, 2024 (trade name Rytelo®), for the treatment of adult patients with lower-risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia.
2025-03-04
2025-03-04
Allbiosyn (Shanghai) Biotechnology Co., Ltd. cordially invites you to visit Booth 66 in Hall SD3 at BIOCHINA2025, to jointly explore the future landscape of nucleic acid technology!
2025-02-28
2025-02-28
2025 New Spring, Allbiosyn Biotechnology embarks on a new journey with you!
As Chinese New Year arrives, auspicious energy descends! Aobai Xin (Shanghai) Biotechnology Co., Ltd., along with all its staff, extends New Year greetings to you!
2025-01-24
Join email subscription
You will receive Allbiosyn's latest product information and recent updates
Wish to receive more updates from Allbiosyn
Stay up-to-date with the latest product releases, technology trends, and upcoming events.
- All
- Product Management
- News Information
- Introduction Content
- Enterprise Outlets
- FAQ
- Corporate Video
- Corporate Album
Phone:+8618666985712
Email:info@allbiosyn.com
WeChat ID: 18666985712
Address: Building 1, 883-885 Pinggang Road, Lingang New Area, Shanghai
Copyright © 2025 Allbiosyn (Shanghai) Biotechnology Co., Ltd. All Rights Reserved.